Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 47335-615

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 47335-615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-norepinephrine-carton (Spl Norepinephrine Carton)

This is a warning label for Norepinephrine Bitartrate Injection, a drug used for intravenous infusion. It contains sulfites and has potent effects that should be monitored through frequent measurements of blood pressure. The label warns against leaving the patient unattended during administration and avoiding extravasation. It also instructs the reader to read prescribing information carefully and dilute the drug before use, discarding any unused portion. The drug is distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ, and was manufactured by Gland Pharma Limited in Hyderabad, India.*

FDA Label Image

Spl-norepinephrine-carton1 (Spl Norepinephrine Carton1)

This is a description of Thoca Norepinephrine Bitartrate Injection, USP used for intravenous infusion only. It contains 1 mg of norepinephrine base per mL and sodium chloride for isotonicity. It cannot be used if the solution has a pinkish color or contains a precipitate. It also contains sodium metabisulfite as an antioxidant and must be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It comes in 10 x 4 mL single-dose flip-top vials which should be used as per the prescribing information. It warns that it contains sulfites and advises against its contact with iron salts, alkalis, or oxidizing agents.*

FDA Label Image

Spl-norepinephrine-structure (Spl Norepinephrine Structure)

FDA Label Image

Spl-norepinephrine-vial (Spl Norepinephrine Vial)

The text appears to be the description of a medication product. It contains information about the quantity of Norepinephrine present in each mL of the injection along with its equivalent in milligrams. It also states that the product needs to be diluted before use and should be protected from light. The product is safe for intravenous use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.